NASDAQ: MDBHMdb Capital Holdings LLC Stock
$2.86-0.30 (-9.49%)
Updated Jun 12, 2026
MDBH Price
$2.86
Fair Value Price
N/A
Market Cap
$29.85M
52 Week Low
$2.50
52 Week High
$5.50
P/E
-1.36x
P/B
0.53x
P/S
7.4x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.13M
Earnings
-$21.39M
Gross Margin
100%
Operating Margin
-518.1%
Profit Margin
-518.4%
Debt to Equity
0.02
Operating Cash Flow
-$4M
Beta
0.26
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MDBH Overview
MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service division provides comprehensive broker-dealer services, focusing on arranging private and public securities offerings, and furnishing research for investment banking due diligence. Meanwhile, the Technology Development division is engaged in the advancement of synthetic biology technology. MDB Capital Holdings, LLC was established in 1997 and is based in Addison, Texas.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MDBH's potential to beat the market
- MDBH doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MDBH news, forecast changes, insider trades & much more!
MDBH News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MDBH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MDBH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MDBH is good value based on its book value relative to its share price (0.53x), compared to the US Capital Markets industry average (3.07x)
P/B vs Industry Valuation
MDBH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MDBH due diligence checks available for Premium users.
Valuation
MDBH fair value
Fair Value of MDBH stock based on Discounted Cash Flow (DCF)
Price
$2.86
Fair Value
$2.63
Overvalued by
8.69%
MDBH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MDBH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.36x
Industry
18.36x
Market
14.15x
MDBH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.53x
Industry
3.07x
MDBH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MDBH's financial health
Profit margin
Revenue
$44.0k
Net Income
-$6.7M
Profit Margin
-15,306.8%
MDBH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$57.5M
Liabilities
$1.2M
Debt to equity
0.02
MDBH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.9k
Investing
-$69.0
Financing
$0.0
MDBH vs Capital Market Stocks
Mdb Capital Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.